Back to Agenda
Session 6: Part 2
Session Chair(s)
Sarah Dunnett
Medical Operations Partner
Sarah Dunnett Consulting Ltd, United Kingdom
For our final conference session, we will hear some different approaches which enrich both the progression and impact of Medical Information. Firstly, we will hear about the personal professional and collective benefits of collaborating across the Spanish Pharmaceutical Industry – we will gain an insight to some great achievements and exciting upcoming developments for Medical Information in Spain. Our second speaker will then share how a company-wide initiative to better understand the patient community and their expectations is being applied by their Medical Information service. As the conference draws to a close, our programme committee will come together to reflect on the conference learnings and how they will impact the future of Medical Information.
Speaker(s)
Advancing the profile of Medical Information through a Professional Organization: Experience in Spain
Angela Flores, MLIS
Lilly Deutschland GmbH, Germany
Medical Information Associate Director
Committee Reflections and Vision
Hakan Aribas, MD
Orion Healthcare Inc., Turkey
Medical Operations Head
Committee Reflections and Vision
Michelle Bridenbaker, BSN, MS
Recordati Rare Diseases, Switzerland
Vice-President at MILE, Head of Global Medical Information,
Committee Reflections and Vision
Peter Brodbin
Pfizer Limited, United Kingdom
Director of Medical Information Effectiveness
Committee Reflections and Vision
Marie-Luise Helmich, PhD
Sanofi, Germany
Head of Europe Medical Information
Committee Reflections and Vision
Sabine Lischka-Wittmann, DrSc
Lilly Deutschland GmbH, Germany
Sr. Director - Medical Information, Europe
Committee Reflections and Vision
Isabelle C. Widmer, DrMed
elytra GmbH, Switzerland
CEO elytra GmbH, Consultant
Have an account?